Remmie is a Techstars/UnitedHealthcare Accelerator company, building the next generation of ENT care data solutions with telemedicine and machine learning. Remmie addresses the pain point of unnecessary ER and specialty visits, gap in chronic routine virtual primary/ENT care engagement, and no reliable remote examination for common acuity ailments (cold/flu/upper respiratory tract infection/allergy) with 140M visits a year impacting each household 2-9 times yearly, resulting in 18 million unnecessary ER visits costing over $18 Billion in the US alone. Remmie builds a virtual care solution suite for ENT and upper respiratory conditions with connected ENT examination devices, API, and AI/ML diagnosis engine, centered around the Remmie Cloud: - Remmie connected devices and Apps (connected otoscope and kit) are used at home for symptom exam and sharing telemedicine visits. - Remmie API seamlessly links devices and symptoms data to EHR and telehealth service platforms - Remmie.ai is NIH-SBIR funded and uniquely capable to harness data and machine learning analytics for clinical diagnosis support and diagnosis. Remmie goes to market B2B2C by providing SaaS subscription services of the Remmie API and Cloud to payers and telehealth providers who distribute devices at volume to patients. Currently generating revenue on device and API subscription, and building AI pipeline.
Is this your company?
Something looks off?
